• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-026
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pericardial Effusion (3271)
Event Date 01/31/2024
Event Type  Injury  
Manufacturer Narrative
An event of pericardial effusion was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Information from the field indicated that pericardial effusion was noted after the procedure and it got worse after the second day.Then, two weeks follow up, pericardial effusion had decreased.Last follow up, the patient had no symptom and images showed minimal pericardial effusion called physiological effusion which is acceptable based on physician's comments.Based on the information received, the cause of the reported pericardial effusion could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event Description
It was reported that on 31 jan.2024, a 26mm amplatzer septal occluder was sceleted for an implant.The device was deployed and released successfully according to the ifu's.Follow up transesophageal echocardiogram (tee) was performed the day after the procedure and pericardial effusion was noted on (b)(6) 2024.Follow up tte on the second day showed that the pericardial effusion got worse.Follow up tte two weeks after showed that the pericardial effusion has decreased.Last follow up tte was performed on (b)(6) 2024.The patient had no symptom and images showed minimal pericardial effusion called physiological effusion which is acceptable based on physician's comments.The patient is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18952378
MDR Text Key338302031
Report Number2135147-2024-01293
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010205
UDI-Public00811806010205
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number9-ASD-026
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-